Search Published Scientific Projects Competitive Products and Technology Patents
Login
Using synthetic biology methods, the Escherichia coli K-12 genome was reduced by making a series of planned, precise deletions. The multiple-deletion series (MDS™) strains (1), with genome reduction of up to 15%, were designed by identifying non-essential
Industry:
Life Sciences
Owner:
Scarab Genomics, LLC
Using synthetic biology methods, the Escherichia coli K-12 genome was reduced by making a series of planned, precise deletions. The multiple-deletion series (MDS™) platform exemplifies the “Clean Genome®” concept, providing bacterial strains with ideal ch
Industry:
Life Sciences
Owner:
Scarab Genomics, LLC
Using synthetic biology methods, the Escherichia coli K-12 genome was reduced by making a series of planned, precise deletions. The multiple-deletion series (MDS™) platform exemplifies the “Clean Genome®” concept, providing bacterial strains with ideal ch
Industry:
Life Sciences
Owner:
Scarab Genomics, LLC
Scarab Genomics has bioengineered the Clean Genome® E. coli by deleting over 15% of the genome. Genome reduction optimizes the E. coli as a biological factory. Elimination of recombinogenic or mobile DNA, toxins and virulence genes and non-essential genes
Industry:
Life Sciences
Owner:
Scarab Genomics, LLC.
Scarab Genomics has bioengineered the Clean Genome® E. coli by deleting over 15% of the genome. Genome reduction optimizes the E. coli as a biological factory. Elimination of recombinogenic or mobile DNA, toxins and virulence genes and non-essential genes
Industry:
Life Sciences
Owner:
Scarab Genomics, LLC.
Scarab Genomics has bioengineered the Clean Genome® E. coli by deleting over 15% of the genome. Genome reduction optimizes the E. coli as a biological factory. Elimination of recombinogenic or mobile DNA, toxins and virulence genes and non-essential genes
Industry:
Life Sciences
Owner:
Scarab Genomics, LLC.
Gain a whole new level of insight into the effectiveness of your food safety efforts with Sample6 Control—our revolutionary environmental monitoring software. This web-based solution lets you easily schedule, monitor, and audit your safety program across
Industry:
Life Sciences
Owner:
Sample6 Technologies
Sample6 Detect is a portfolio of revolutionary diagnostics for bacteria in food industry environments. Instead of waiting days for results, users can now detect pathogens in hours. Features include: Results in-shift No enrichment Safe and
Industry:
Life Sciences
Owner:
Sample6 Technologies
Prokarium’s ORT-VAC™ technology (Operator-Repressor Titration for Vaccines) is the only selectable marker-free plasmid stabilisation technology that can function with any type of plasmid, enabling recombinant antigens to be delivered orally. With ORT-VAC
Industry:
Pharma
Owner:
Prokarium
MU1140 has demonstrated activity against a wide variety of disease-causing Gram positive bacteria, including MRSA, VRE, C. diff., Mycobacterium tuberculosis, or M. tuberculosis, and anthrax. We have performed extensive preclinical testing on MU1140, which
Industry:
Pharma
Owner:
Oragenics Inc
GRAMMR gene shuffling technology represents a revolutionary advance in protein engineering. Unconstrained by the limitations of conventional methodologies, GRAMMR maximizes natural diversity at the outset. Enhanced diversity shuffling further explores com
Industry:
Life Sciences
Owner:
Novici Biotech LLC
Novici’s patented GRAMMR technology harnesses maximum genetic diversity and rapidly directs desired trait evolution for optimal product performance and gene expression. • Unrestricted initial gene variation delivers maximum diversity for robust genetic f
Industry:
Life Sciences
Owner:
Novici Biotech LLC
Our custom DNA oligos are made to your specifications, with rigorous quality control and quick turnaround. They can be used in a variety of applications, including PCR, cloning, sequencing, and gene detection. A variety of scales, formats, modifications,
Industry:
Life Sciences
Owner:
Life Technologies Corporation (Invitrogen, Geneart, Applied Biosystems)
Gateway® recombination cloning technology allows gene shuttling, enabling you to access virtually any expression system. Gateway® recombination cloning technology circumvents traditional restriction enzyme based cloning limitations, enabling you to access
Industry:
Life Sciences
Owner:
Life Technologies Corporation (Invitrogen, Geneart, Applied Biosystems)
Full-insert sequenced open reading frames (ORFs) of human and mouse clones. Fast Track to Expression and Analysis Vast selection – over 16,000 Ultimate™ Human ORF Clones and over 2,500 Ultimate™ Mouse ORF Clones Gateway® entry clone format –
Industry:
Life Sciences
Owner:
Life Technologies Corporation (Invitrogen, Geneart, Applied Biosystems)
GeneArt® Algae Expression and Engineering Kits Chlamydomonas reinhardtii 137c and Synechococcus elongatus PPC 7942 are the first commercially available genetic modification and expression systems for photosynthetic microalgae. Our most recent GeneArt® kit
Industry:
Life Sciences
Owner:
Life Technologies Corporation (Invitrogen, Geneart, Aplied Biosistems)
Simple, convenient, and highly efficient means to generate mutations. Robust, high-efficiency systems and kits to streamline your workflow Speed—time-to-results is typically less than 3 hours for 3 kb plasmid Precision—alter up to 25 nucleotid
Industry:
Life Sciences
Owner:
Life Technologies Corporation (Invitrogen, Geneart, Aplied Biosistems)
Industry:
Life Sciences
Owner:
Life Technologies Corporation (Invitrogen, Geneart, Aplied Biosistems)
Expert Vector Construction with GeneArt® Seamless Cloning & Assembly tools.
Industry:
Life Sciences
Owner:
Life Technologies Corporation (Invitrogen, Geneart, Aplied Biosistems)
GeneArt® Strings™ DNA Fragments are custom-made linear, double-stranded DNA fragments up to 1,000 bp in length, assembled from synthetic oligonucleotides using the same process developed for GeneArt® high-quality gene synthesis. At least 200 ng of Strings
Industry:
Life Sciences
Owner:
Life Technologies Corporation